X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (18) 18
chemotherapy (17) 17
index medicus (16) 16
humans (14) 14
cancer (12) 12
leukemia (10) 10
animals (9) 9
antineoplastic agents - pharmacology (8) 8
sonodynamic therapy (8) 8
pharmacology (7) 7
cancer research (6) 6
cytochalasin b - pharmacology (6) 6
mice (6) 6
pharmacology & pharmacy (6) 6
research (6) 6
ultrasound (6) 6
apoptosis (5) 5
cell line, tumor (5) 5
doxorubicin (5) 5
drug resistance (5) 5
medicine & public health (5) 5
pharmacology/toxicology (5) 5
u937 cells (5) 5
antineoplastic agents - therapeutic use (4) 4
cancer therapies (4) 4
care and treatment (4) 4
cytochalasin b (4) 4
cytochalasin-b (4) 4
cytochalasins - pharmacology (4) 4
cytoskeleton - drug effects (4) 4
dose-response relationship, drug (4) 4
drug therapy (4) 4
hematology (4) 4
metastasis (4) 4
methods (4) 4
neoplasms - drug therapy (4) 4
studies (4) 4
ultrasonic therapy - methods (4) 4
actin (3) 3
analysis (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - administration & dosage (3) 3
article (3) 3
cytochalasins - chemistry (3) 3
cytoskeletal-directed agents (3) 3
dosage and administration (3) 3
doxorubicin - pharmacology (3) 3
drug synergy (3) 3
induced peripheral neuropathy (3) 3
leukemia - therapy (3) 3
leukemia-cells (3) 3
lung carcinoma (3) 3
lung neoplasms - drug therapy (3) 3
mechanism (3) 3
mechanisms (3) 3
multinucleation (3) 3
preclinical studies (3) 3
review (3) 3
usage (3) 3
vitro (3) 3
actin cytoskeleton (2) 2
agent adriamycin (2) 2
alkylating agents (2) 2
alkylation (2) 2
anthracyclines (2) 2
apoptosis induction (2) 2
b-induced multinucleation (2) 2
biomedicine (2) 2
biomedicine general (2) 2
breast-cancer (2) 2
cancer-cells (2) 2
carbohydrate analogs (2) 2
carcinoma (2) 2
cell death - drug effects (2) 2
cell proliferation - drug effects (2) 2
cell survival - drug effects (2) 2
chemistry, medicinal (2) 2
clinical trials (2) 2
combined modality therapy (2) 2
cytochalasin b - administration & dosage (2) 2
cytochalasins (2) 2
cytochalasins - administration & dosage (2) 2
cytochalasins - therapeutic use (2) 2
drug evaluation, preclinical (2) 2
drug screening assays, antitumor (2) 2
drug-resistance (2) 2
drug-resistant phenotype (2) 2
f-actin (2) 2
gene expression (2) 2
genetic aspects (2) 2
genetics (2) 2
health aspects (2) 2
hearing-loss (2) 2
hematology, oncology and palliative medicine (2) 2
in-vitro (2) 2
induced apoptosis (2) 2
inhibitor drugs (2) 2
leukaemia (2) 2
leukemia - pathology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Drugs, ISSN 0012-6667, 11/2015, Volume 75, Issue 17, pp. 1993 - 2016
Through years of evolutionary selection pressures, organisms have developed potent toxins that coincidentally have marked antineoplastic activity. These... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | IMMUNOTOXIN RFB4(DSFV)-PE38 BL22 | PEGYLATED LIPOSOMAL DOXORUBICIN | EPOTHILONE-B ANALOG | DRUG-RESISTANT PHENOTYPE | GEMTUZUMAB OZOGAMICIN | PHASE-I TRIAL | METASTATIC BREAST-CANCER | ERIBULIN MESYLATE E7389 | PHARMACOLOGY & PHARMACY | TOXICOLOGY | ANTI-MESOTHELIN IMMUNOTOXIN | CHRONIC MYELOID-LEUKEMIA | Dioxoles - therapeutic use | Diphtheria Toxin - pharmacology | Recombinant Fusion Proteins - pharmacology | Furans - pharmacology | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Epothilones - pharmacology | Drug Discovery - methods | Antineoplastic Agents - therapeutic use | Biological Products - pharmacology | Epothilones - therapeutic use | Harringtonines - therapeutic use | Furans - therapeutic use | TOR Serine-Threonine Kinases - antagonists & inhibitors | Diphtheria Toxin - therapeutic use | Immunoconjugates - pharmacology | Cytochalasins - pharmacology | Dioxoles - pharmacology | Immunoconjugates - therapeutic use | Antineoplastic Agents - pharmacology | Ketones - therapeutic use | Cytochalasins - therapeutic use | Biological Products - therapeutic use | Ketones - pharmacology | Tetrahydroisoquinolines - pharmacology | Tetrahydroisoquinolines - therapeutic use | Withanolides - pharmacology | Harringtonines - pharmacology | Interleukin-2 - pharmacology | Withanolides - therapeutic use | Antimitotic agents | Care and treatment | Chemotherapy | Usage | Clinical trials | Dosage and administration | Diagnosis | Antineoplastic agents | Cancer | Index Medicus | Review
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2015, Volume 21, Issue 17 Supplement, pp. B37 - B37
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 1640 - 1640
Journal Article
Critical Reviews in Oncology/Hematology, ISSN 1040-8428, 05/2015, Volume 94, Issue 2, pp. 149 - 163
Nearly all cancers are linked by the inexorable phenotype of metastasis as malignant growths have the capability to spread from their place of origin to... 
Chemotherapy | Sonodynamic therapy | Leukocytes | Metastasis | Drug resistance | Ultrasound | Leukaemia
Journal Article
Pharmacological Research, ISSN 1043-6618, 09/2015, Volume 99, pp. 202 - 216
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2014, Volume 94, Issue 2, pp. 149 - 163
Journal Article
Chemotherapy Research and Practice, ISSN 2090-2107, 2015, Volume 2015, pp. 316015 - 16
Sonodynamic therapy (SDT) is a form of ultrasound therapy in which specialized chemotherapeutic agents known as sonosensitizers are administered to increase... 
Chemotherapy | Usage | Care and treatment | Leukemia | Ultrasonic waves | Research | Methods | Cancer | Review
Journal Article
Journal Article
Biochimica et biophysica acta, ISSN 0006-3002, 12/2014, Volume 1846, Issue 2, p. 599
Although cytoskeletal-directed agents have been a mainstay in chemotherapeutic protocols due to their ability to readily interfere with the rapid mitotic... 
Staurosporine - therapeutic use | Humans | Indole Alkaloids - therapeutic use | Depsipeptides - therapeutic use | Neoplasms - ultrastructure | Cytochalasins - therapeutic use | Cytoskeleton - drug effects | Neoplasms - drug therapy
Journal Article